Compounds > lovastatin
Page last updated: 2024-08-23

lovastatin and Cancer of Esophagus

lovastatin has been researched along with Cancer of Esophagus in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guan, BX; Xu, XC; Ye, F; Zhang, GH1
Shi, J; Xu, Z; Yao, F; Zhao, H; Zhong, C; Zhu, J1
Beales, IL; Ogunwobi, OO1
Hawk, ET; Viner, JL1

Other Studies

4 other study(ies) available for lovastatin and Cancer of Esophagus

ArticleYear
Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin.
    World journal of gastroenterology, 2012, Jan-14, Volume: 18, Issue:2

    Topics: Animals; Anticarcinogenic Agents; Anticholesteremic Agents; Catechin; Cell Line, Tumor; Curcumin; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Esophageal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Lovastatin; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous

2012
Mevalonate pathway is a therapeutic target in esophageal squamous cell carcinoma.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2013, Volume: 34, Issue:1

    Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Extracellular Signal-Regulated MAP Kinases; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; MAP Kinase Signaling System; Mevalonic Acid; Mice; Mice, Nude; Neoplasm Transplantation; Poly(ADP-ribose) Polymerases; Proliferating Cell Nuclear Antigen; Transplantation, Heterologous

2013
Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
    The American journal of gastroenterology, 2008, Volume: 103, Issue:4

    Topics: Adenocarcinoma; Analysis of Variance; Animals; Apoptosis; Barrett Esophagus; Caspase 3; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Esophageal Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Lovastatin; Mevalonic Acid; Nitrobenzenes; Polyisoprenyl Phosphates; Pravastatin; Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Signal Transduction; Simvastatin; Sulfonamides

2008
Statins in esophageal cancer cell lines: promising lead?
    The American journal of gastroenterology, 2008, Volume: 103, Issue:4

    Topics: Adenocarcinoma; Animals; Apoptosis; Barrett Esophagus; Cell Line, Tumor; Dose-Response Relationship, Drug; Esophageal Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Simvastatin

2008